LON:MRL

Marlowe Share Forecast, Price & News

GBX 871
+16.00 (+1.87 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
856
876
50-Day Range
740
866
52-Week Range
470
876
Volume113,215 shs
Average Volume241,864 shs
Market Capitalization£671.75 million
P/E Ratio2,903.33
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MRL News and Ratings via Email

Sign-up to receive the latest news and ratings for Marlowe and its competitors with MarketBeat's FREE daily newsletter.


Marlowe logo

About Marlowe

Marlowe plc provides water treatment, air hygiene, health and safety, and risk and compliance software services in the United Kingdom. The company operates through two segments, Risk Management & Compliance, and Water Treatment & Air Quality. It provides health and safety, HR compliance, occupational health, and risk management software; designs, installs, and maintains fire protection and security systems; and provides integrated water treatment, hygiene, testing, monitoring, wastewater, and engineering services. The company is also involved in the provision of testing, inspection and risk assessment, ventilation hygiene compliance, ductwork management and fire safety, extract cleaning, asbestos consultancy, air monitoring and clearance testing, and bulk identification and sampling services. Its customers include office complexes, streets and leisure facilities, manufacturing plants and industrial estates, SMEs, local authorities, facilities management providers, NHS trusts, and FTSE 100 companies. The company was formerly known as Marlowe Holdings Limited. Marlowe plc was founded in 2015 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.90 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Marlowe (LON:MRL) Frequently Asked Questions

Is Marlowe a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Marlowe in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Marlowe stock.
View analyst ratings for Marlowe
or view top-rated stocks.

What stocks does MarketBeat like better than Marlowe?

Wall Street analysts have given Marlowe a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Marlowe wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Marlowe's next earnings date?

Marlowe is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for Marlowe
.

How has Marlowe's stock been impacted by COVID-19?

Marlowe's stock was trading at GBX 436 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MRL shares have increased by 99.8% and is now trading at GBX 871.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for MRL?

4 equities research analysts have issued twelve-month price objectives for Marlowe's shares. Their forecasts range from GBX 870 to GBX 951. On average, they expect Marlowe's share price to reach GBX 918 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price.
View analysts' price targets for Marlowe
or view top-rated stocks among Wall Street analysts.

Who are Marlowe's key executives?

Marlowe's management team includes the following people:
  • Mr. Alex Dacre, CEO & Director
  • Mr. Mark Andrew Adams, Group Fin. Director & Director (Age 56, Pay $209k)
  • Peter Bell, Group Chief Technology Officer
  • Mr. Robert Flinn, Chief Exec. of the Fire businesses (Age 49)
  • Phil Greenwood, Chief Exec. of Water Bus.es
  • Beatriz Shorrock, Managing Director of Health & Safety
  • Mr. Matthew Allen, Company Sec.
  • John Wills, Software Director

Who are some of Marlowe's key competitors?

What other stocks do shareholders of Marlowe own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marlowe investors own include Stobart Group Limited (STOB.L) (STOB) and Legal & General Group (LGEN).

What is Marlowe's stock symbol?

Marlowe trades on the London Stock Exchange (LON) under the ticker symbol "MRL."

How do I buy shares of Marlowe?

Shares of MRL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Marlowe's stock price today?

One share of MRL stock can currently be purchased for approximately GBX 871.

How much money does Marlowe make?

Marlowe has a market capitalization of £671.75 million and generates £181.30 million in revenue each year.

How many employees does Marlowe have?

Marlowe employs 2,500 workers across the globe.

What is Marlowe's official website?

The official website for Marlowe is www.marloweplc.com.

Where are Marlowe's headquarters?

Marlowe is headquartered at 20 Grosvenor Place, LONDON, SW1X 7HN, United Kingdom.

How can I contact Marlowe?

Marlowe's mailing address is 20 Grosvenor Place, LONDON, SW1X 7HN, United Kingdom. The company can be reached via phone at +44-20-38138498.


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.